Stay updated with breaking news from Longitudinal Assessment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.
Dr. Aftab objects to my "tirade against psychiatric neuroscience." What Dr. Aftab does not do is address any of my substantive conclusions.
New Patent Covers Over 150 Novel CompoundsMELBOURNE, Australia and SAN FRANCISCO, Aug. 23, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying...
The U.S. Food and Drug Administration (FDA) has issued a Letter to Health Care Providers about updated information associated with paclitaxel-coated devices used to treat peripheral arterial disease (PAD)